UK off-patent body the British Generic Manufacturers Association has named Sandoz UK head Diane DiGangi Trench as its vice chair, replacing Xiromed’s Peter Ballard. Moreover, the BGMA has confirmed that in 12 months, DiGangi Trench will move up to become the association’s chair, taking over from Accord’s Peter Kelly.
BGMA Lines Up New Leadership With Change Of Vice-Chair
Sandoz UK Head Diane DiGangi Trench Will Become Chair Of British Body Next Year
UK generics and biosimilars industry association the BGMA is laying the groundwork for new leadership after appointing Sandoz UK head Diane DiGangi Trench as its vice-chair, ahead of her moving up to chair next year.
More from Leadership
More from Generics Bulletin
• By
Amgen told investors during its 1 May first-quarter earnings call that its Pavblu biosimilar to Eylea 2mg had flown out of the gates, while Regeneron admitted “some difficult news related to our retinal franchise.”
• By
The UK generics and biosimilars industry will now be represented by Medicines UK, the new name for the former British Generic Manufacturers Association.
• By
Stelara originator J&J has been denied in its initial attempt to prevent Samsung Bioepis and ustekinumab biosimilar partner Sandoz from selling a private-label version of the product through a PBM in the US.